BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olaleye OA, Kaur M, Onyenaka C, Adebusuyi T. Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro. Heliyon 2021;7:e06426. [PMID: 33732940 DOI: 10.1016/j.heliyon.2021.e06426] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Uhomoibhi JO, Idowu KA, Shode FO, Sabiu S. Molecular modeling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins. Sci Afr 2022;17:e01279. [PMID: 35856008 DOI: 10.1016/j.sciaf.2022.e01279] [Reference Citation Analysis]
2 Puhl AC, Mottin M, Sacramento CQ, Tavella TA, Dias GG, Fintelman-rodrigues N, Temerozo JR, Dias SSG, Ramos PRPDS, Merten EM, Pearce KH, Costa FTM, Premkumar L, Souza TML, Andrade CH, Ekins S. Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors. ACS Omega. [DOI: 10.1021/acsomega.2c01707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wei H, Zhang C, Du X, Zhang Z. Research progress of biosensors for detection of SARS-CoV-2 variants based on ACE2. Talanta 2022. [DOI: 10.1016/j.talanta.2022.123813] [Reference Citation Analysis]
4 Wykowski R, Fuentefria AM, de Andrade SF. Antimicrobial activity of clioquinol and nitroxoline: a scoping review. Arch Microbiol 2022;204:535. [PMID: 35907036 DOI: 10.1007/s00203-022-03122-2] [Reference Citation Analysis]
5 Kehinde IA, Egbeyemi A, Kaur M, Onyenaka C, Adebusuyi T, Olaleye OA. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike. J Biomol Struct Dyn 2022;:1-10. [PMID: 35220925 DOI: 10.1080/07391102.2022.2043938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ghobashy MM, Alshangiti DM, Alkhursani SA, Al-gahtany SA, Meganid AS, Madani M, Kodous AS. Aspects of the physiochemical properties of SARS-CoV-2 to prevent S-protein receptor binding using Arabic gum. Green Processing and Synthesis 2022;11:150-63. [DOI: 10.1515/gps-2022-0018] [Reference Citation Analysis]
7 Prachayasittikul V, Pingaew R, Prachayasittikul S, Prachayasittikul V. 8-Hydroxyquinolines: A Promising Pharmacophore Potentially Developed as Disease-Modifying Agents for Neurodegenerative Diseases: A Review. HETEROCYCLES 2022;105:202. [DOI: 10.3987/rev-22-sr(r)6] [Reference Citation Analysis]
8 O'Donnell HR, Tummino TA, Bardine C, Craik CS, Shoichet BK. Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens. J Med Chem 2021;64:17530-9. [PMID: 34812616 DOI: 10.1021/acs.jmedchem.1c01547] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
9 Aherfi S, Pradines B, Devaux C, Honore S, Colson P, Scola B, Raoult D. Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV. Future Microbiol 2021;16:1341-70. [PMID: 34755538 DOI: 10.2217/fmb-2021-0019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
10 Oâ Donnell HR, Tummino TA, Bardine C, Craik CS, Shoichet BK. Colloidal aggregators in biochemical SARS-CoV-2 repurposing screens. bioRxiv 2021:2021. [PMID: 34494023 DOI: 10.1101/2021.08.31.458413] [Reference Citation Analysis]
11 Roth S, Danielli A. Rapid and Sensitive Inhibitor Screening Using Magnetically Modulated Biosensors. Sensors (Basel) 2021;21:4814. [PMID: 34300555 DOI: 10.3390/s21144814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]